Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT01267812
Title Bortezomib and Rituximab in Treating Patients With Mantle Cell Lymphoma Who Have Previously Undergone Stem Cell Transplantation
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors City of Hope Medical Center

mantle cell lymphoma


Bortezomib + Rituximab

Age Groups: adult
Covered Countries USA

No variant requirements are available.